Trademark: 90818374
Status Date
Tuesday, May 2, 2023
Registration Number
7044077
Registration Date
Tuesday, May 2, 2023
Filing Date
Thursday, July 8, 2021
Published for Opposition
Tuesday, May 3, 2022
5 pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis (FSGS); pharmaceutical preparations for the treatment of Immunoglobulin A Nephropathy (IgAN); pharmaceutical preparations for the treatment of Alport Syndrome
May 2, 2023
Notice Of Registration Confirmation Emailed
May 2, 2023
Registered-Principal Register
Mar 31, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Mar 30, 2023
Allowed Principal Register - Sou Accepted
Mar 9, 2023
Statement Of Use Processing Complete
Feb 22, 2023
Use Amendment Filed
Mar 9, 2023
Case Assigned To Intent To Use Paralegal
Feb 22, 2023
Teas Statement Of Use Received
Dec 22, 2022
Notice Of Approval Of Extension Request E-Mailed
Dec 20, 2022
Sou Extension 1 Granted
Dec 20, 2022
Sou Extension 1 Filed
Dec 20, 2022
Sou Teas Extension Received
Jun 28, 2022
Noa E-Mailed - Sou Required From Applicant
May 3, 2022
Official Gazette Publication Confirmation E-Mailed
May 3, 2022
Published For Opposition
Apr 13, 2022
Notification Of Notice Of Publication E-Mailed
Mar 28, 2022
Approved For Pub - Principal Register
Mar 28, 2022
Assigned To Examiner
Sep 16, 2021
New Application Office Supplied Data Entered
Jul 12, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
